A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT05098145 · WITHDRAWN
Trial details
- NCT number
- NCT05098145
- Sponsor
- Talaris Therapeutics Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2026-11-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.